Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
Completed · Phase 3
Conditions studied: Hepatitis C, Genotype 1
In brief
The purpose of this open label study is to evaluate the safety and efficacy of daclatasvir plus pegylated interferon-alfa 2a and ribavirin in untreated hepatitis C virus in patients coinfected with HIV
Key facts
- Study ID
- NCT01471574
- Run by
- Bristol-Myers Squibb
- People needed
- 549
- Starts
- 2011-12-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2016-01-29
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Scripps Clinic — La Jolla, California, United States
- Southern California Permanente Medical Group — Los Angeles, California, United States
- Desert Medical Group Inc. — Palm Springs, California, United States
- Ucsd Antiviral Research Center — San Diego, California, United States
- San Francisco Gen Hosp — San Francisco, California, United States
- Kaiser Permanente Medical Center — San Francisco, California, United States
- Va Connecticut Healthcare System — West Haven, Connecticut, United States
- Georgetown University Hospital — Washington D.C., District of Columbia, United States
- University Of Miami School Of Medicine — Miami, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- Johns Hopkins University — Lutherville, Maryland, United States
- Saint Michael'S Medical Center — Newark, New Jersey, United States
- Upper Delaware Valley Infectious Diseases, Pc — Monticello, New York, United States
- Icahn School Of Medicine At Mount Sinai — New York, New York, United States
- Weill Cornell Medical College — New York, New York, United States
- James J Peters Vamc — The Bronx, New York, United States
- University Of North Carolina At Chapel Hill — Chapel Hill, North Carolina, United States
- Morehead Medical Plaza — Charlotte, North Carolina, United States
- Amelia Court Hiv Research Clinic — Dallas, Texas, United States
- Baylor College Of Medicine — Houston, Texas, United States
- Texas Liver Institute — San Antonio, Texas, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- University Of Alabama At Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.